The Abca4 KO mouse treatment resulted in expression of ABCA4 within the photoreceptor outer-segments [173,177], expression of ABCA4 beyond the treated region [173], a significant reduction in bisretinoid levels [173,177], and a reduction in AF signal [173]. This evidence concerns the gene ABCA4 and atrial fibrillation.